Showing 11,021 - 11,040 results of 24,418 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 100 ((a decrease) OR (we decrease)) ))', query time: 1.08s Refine Results
  1. 11021

    Table 1_Diverging trends in the global burden of ischemic heart disease attributable to non-optimal temperatures: a historical analysis (1990–2021) and 2050 projections.docx by Zehao Jin (11408687)

    Published 2025
    “…Analysis of the Bayesian modeling projections for 2050 revealed divergent trajectories: high non-optimal temperature-related age-standardized death rates and DALYs rates are likely to increase by 2.85 per 100,000 and 66.83 per 100,000, respectively. In contrast, age-standardized mortality rates associated with low non-optimal temperature are anticipated to decrease by 6.08 per 100,000, reflecting continued adaptation and improved healthcare infrastructure.…”
  2. 11022

    Table 1_Association between platelet count and 30-day in-hospital mortality among intensive care unit patients with sepsis: a multicenter retrospective cohort study.docx by Jun Wang (5906)

    Published 2025
    “…Below this threshold, each 10 × 10⁹/L increase in platelet count was associated with a 6% decrease in mortality risk (adjusted OR 0.94, 95% CI 0.93–0.95, p < 0.0001), while above it, each 10 × 10⁹/L increase was associated with a 1% increase in mortality risk (adjusted OR 1.01, 95% CI 1.00–1.01, p = 0.0153).…”
  3. 11023

    Data Sheet 1_Application of radiomics-based prediction model to predict preoperative lymph node metastasis in prostate cancer: a systematic review and meta-analysis.docx by Yanghuang Zheng (21575123)

    Published 2025
    “…Radiomics features without intraclass correlation coefficient preprocessing would lead to a decrease in diagnostic specificity, 0.73 (95% CI [0.53 - 0.92]) (p = 0.04). …”
  4. 11024

    Table_1_Long-term trends of HIV/AIDS incidence in India: an application of joinpoint and age–period–cohort analyses: a gendered perspective.docx by Neha Shri (12057202)

    Published 2023
    “…The average annual percentage changes in the incidence were computed, and the age–period–cohort analysis was performed.</p>Results<p>A decreasing trend in the overall estimates of age-standardized HIV incidence rates were observed in the period 1990–2019. …”
  5. 11025

    Table 1_Down syndrome burden in China and globally: a comparative analysis of 1990–2021 trends and future projections based on GBD 2021 database.xlsx by Xiangwen Tu (20471360)

    Published 2025
    “…</p>Results<p>From 1990 to 2021, China’s ASIR decreased from 1.68 per 100,000 to 1.18 per 100,000, compared to a global reduction from 1.27 per 100,000 to 0.97 per 100,000. …”
  6. 11026

    Table 2_Down syndrome burden in China and globally: a comparative analysis of 1990–2021 trends and future projections based on GBD 2021 database.xlsx by Xiangwen Tu (20471360)

    Published 2025
    “…</p>Results<p>From 1990 to 2021, China’s ASIR decreased from 1.68 per 100,000 to 1.18 per 100,000, compared to a global reduction from 1.27 per 100,000 to 0.97 per 100,000. …”
  7. 11027

    Table 4_Down syndrome burden in China and globally: a comparative analysis of 1990–2021 trends and future projections based on GBD 2021 database.xlsx by Xiangwen Tu (20471360)

    Published 2025
    “…</p>Results<p>From 1990 to 2021, China’s ASIR decreased from 1.68 per 100,000 to 1.18 per 100,000, compared to a global reduction from 1.27 per 100,000 to 0.97 per 100,000. …”
  8. 11028

    Table 3_Down syndrome burden in China and globally: a comparative analysis of 1990–2021 trends and future projections based on GBD 2021 database.xlsx by Xiangwen Tu (20471360)

    Published 2025
    “…</p>Results<p>From 1990 to 2021, China’s ASIR decreased from 1.68 per 100,000 to 1.18 per 100,000, compared to a global reduction from 1.27 per 100,000 to 0.97 per 100,000. …”
  9. 11029

    Phylogenetic Impoverishment of Amazonian Tree Communities in an Experimentally Fragmented Forest Landscape by Bráulio A. Santos (242306)

    Published 2014
    “…Consistent with this loss in phylogenetic diversity, we observed a significant decrease of 50% in phylogenetic dispersion since forest isolation, irrespective of plot location. …”
  10. 11030

    Table 1_Global, regional, and national disease burden and economic costs of cervical cancer (1991–2021): a multidimensional data synthesis analysis.docx by Yidi Ma (9507153)

    Published 2025
    “…Objectives<p>Cervical cancer remains a significant global health concern, particularly in less developed regions. …”
  11. 11031

    DataSheet1_Alnus hirsuta (Spach) Rupr. Attenuates Airway Inflammation and Mucus Overproduction in a Murine Model of Ovalbumin-Challenged Asthma.docx by Ba-Wool Lee (7159763)

    Published 2021
    “…In this study, we investigated the protective effects of a methanolic extract of AH branches against airway inflammation and mucus production in tumor necrosis factor (TNF)-α-stimulated NCI-H292 cells and in an ovalbumin (OVA)-challenged allergic asthma mouse model. …”
  12. 11032

    DataSheet_1_Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020.x... by Zoltán Kiss (5570003)

    Published 2023
    “…Age-standardized incidence rates varied between 116.73 and 106.16/100,000 PYs, showing a mean annual change of -0.7% (95% CI: -1.21%–0.16%) and a total change of -5.41% (95% CI: -9.24 to -1.32). …”
  13. 11033

    Increase in conjugated linoleic acid content and improvement in microbial and physicochemical properties of a novel kefir stored at refrigerated temperature using complementary pro... by Hamid POURBABA (10465398)

    Published 2021
    “…A 4-fold increase in the acetic acid value (0.592 g/100 mL) was observed in kefirs supplemented with B. lactis BB-12 along with L. acidophilus LA-5 and L. paracasei 431 (G12). …”
  14. 11034

    Additional file 3 of C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties by Monique van Es-Remers (13895294)

    Published 2022
    “…In this assay C. elegans was exposed to different concentrations (5, 50 and 100 μg/mL) of the Non-Polar Fractions both in carboxylated (NPFdec) and non-decarboxylated (NPF) form. …”
  15. 11035

    File S1 - Impact of Glucocorticoid Receptor Density on Ligand-Independent Dimerization, Cooperative Ligand-Binding and Basal Priming of Transactivation: A Cell Culture Model by Steven Robertson (414616)

    Published 2013
    “…Exposure times of 1500 ms at 100% light intensity were used. F-don values reflect the CFP signal after 30 minutes of DEX stimulation measured in a region of interest in the nucleus of each individual cell. …”
  16. 11036

    Effect of a roadblock on ParB2-mediated stimulation of <i>oriII</i> activity in <b><i>E. coli</i></b>. by Tatiana Venkova-Canova (424756)

    Published 2013
    “…<p>Two <i>oriII</i> plasmids, pTVC20 and pBJH218, isogenic except for about 100 bp extra sequences carrying an array of five P1 RepA binding sites (iterons) in the latter, were used to transform BR8706 (<i>recA</i> minus) cells without (#1, #2) and with (#3, #4) an integrated λ prophage (λDKC311). …”
  17. 11037

    Neuroprotective effect of NX210 against H<sub>2</sub>O<sub>2</sub> using a B104 cell line. by Laurent Sakka (542426)

    Published 2014
    “…<p>Neuroprotective effect of NX210 at 100 and 250 μg/ml was assessed by the resistance of a B104 neuroblastoma cell line after 18 hours of exposure to H<sub>2</sub>O<sub>2</sub>. …”
  18. 11038

    Analysis of targeted MLX deletion in Sertoli cells. by Patrick A. Carroll (11586792)

    Published 2021
    “…<p>(<b>A</b>) IF for the Sertoli cell marker SOX9 in WT and MLX<sup>KO</sup> testes with acellular tubules indicated with asterisks (100×, scale bar = 400 uM). …”
  19. 11039

    Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study by Christian Wolf (385271)

    Published 2013
    “…<div><p>Background</p><p>Lymphocyte inhibition by antagonism of α4 integrins is a validated therapeutic approach for relapsing multiple sclerosis (RMS).…”
  20. 11040